Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Greenlights Generic Vyvanse

The approval offers a more accessible alternative for managing ADHD and binge eating disorder.

Screen Shot 2022 04 18 At 2 47 13 Pm
Getty Images

According to a recent Forbes article, the FDA has taken a major step toward addressing the shortage of ADHD medications by granting approval for generic versions of Vyvanse, an increasingly sought-after alternative to Adderall. Vyvanse, commonly prescribed for ADHD and binge eating disorder, is used by over one million Americans. Previously manufactured exclusively by Takeda Pharmaceuticals, Vyvanse has generated substantial revenue, becoming Takeda's third-largest drug, with annual sales exceeding $2.5 billion.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO